Trial Profile
Weekly Administration of (bi-)Daily Oral Docetaxel in Combination With Ritonavir.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Oct 2021
Price :
$35
*
At a glance
- Drugs Docetaxel/ritonavir (Primary)
- Indications Cancer; Solid tumours
- Focus Adverse reactions; Pharmacogenomic
- 03 Jan 2019 Status changed from active, no longer recruiting to completed.
- 23 Dec 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 23 Dec 2010 Actual initiation date changed from Aug 2010 to Sep 2010 as reported by ClinicalTrials.gov.